Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Claudin-7 indirectly regulates the integrin/FAK signaling pathway in human colon cancer tissue
Authors
Keywords
-
Journal
JOURNAL OF HUMAN GENETICS
Volume 61, Issue 8, Pages 711-720
Publisher
Springer Nature
Online
2016-04-28
DOI
10.1038/jhg.2016.35
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Analyses of Microarray Datasets Identifies ANO1 and FADD as Prognostic Markers of Head and Neck Cancer
- (2016) Ram Bhupal Reddy et al. PLoS One
- MiR-124 suppresses cell motility and adhesion by targeting talin 1 in prostate cancer cells
- (2015) Wei Zhang et al. Cancer Cell International
- RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy
- (2015) Qianyi Lu et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- Radiation sensitization of tumor cells induced by shear stress: The roles of integrins and FAK
- (2014) Chi-Wen Luo et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- MAPK signaling control of colon cancer metastasis
- (2014) Jelena Urosevic et al. CELL CYCLE
- Claudin-7 expression induces mesenchymal to epithelial transformation (MET) to inhibit colon tumorigenesis
- (2014) A A Bhat et al. ONCOGENE
- Loss of tight junction proteins (Claudin 1, 4, and 7) correlates with aggressive behavior in colorectal carcinoma
- (2014) Cem Sezer MEDICAL SCIENCE MONITOR
- Cancer statistics, 2013
- (2013) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Dietary Influence on MAPK-Signaling Pathways and Risk of Colon and Rectal Cancer
- (2013) Martha L. Slattery et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Fibronectin extra domain A (EDA) sustains CD133+/CD44+ subpopulation of colorectal cancer cells
- (2013) Juanjuan Ou et al. Stem Cell Research
- Overexpression of lumican affects the migration of human colon cancer cells through up-regulation of gelsolin and filamentous actin reorganization
- (2012) Agata Radwanska et al. EXPERIMENTAL CELL RESEARCH
- Regulation of adrenocortical steroid hormone production by RhoA–diaphanous 1 signaling and the cytoskeleton
- (2012) Marion B. Sewer et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- The level of claudin-7 is reduced as an early event in colorectal carcinogenesis
- (2011) Jette Bornholdt et al. BMC CANCER
- Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway
- (2011) Zhe Lu et al. EXPERIMENTAL CELL RESEARCH
- Inflammation and Disruption of the Mucosal Architecture in Claudin-7–Deficient Mice
- (2011) Lei Ding et al. GASTROENTEROLOGY
- Integrative, Multimodal Analysis of Glioblastoma Using TCGA Molecular Data, Pathology Images, and Clinical Outcomes
- (2011) Jun Kong et al. IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING
- SAM: String-based sequence search algorithm for mitochondrial DNA database queries
- (2010) Alexander Röck et al. Forensic Science International-Genetics
- The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored
- (2010) D. Szklarczyk et al. NUCLEIC ACIDS RESEARCH
- Land-use intensification reduces functional redundancy and response diversity in plant communities
- (2009) Etienne Laliberté et al. ECOLOGY LETTERS
- β1 integrin/FAK/ERK signalling pathway is essential for human fetal islet cell differentiation and survival
- (2009) Saira Saleem et al. JOURNAL OF PATHOLOGY
- Extracellular matrix regulation of autophagy
- (2008) Rebecca Lock et al. CURRENT OPINION IN CELL BIOLOGY
- In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma
- (2008) Fabien Gay et al. HUMAN PATHOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started